COMUNICADO: Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With

Actualizado 21/04/2009 1:02:18 CET

(6) Siebert U, Muhlberger N and Zeuzem S. Pan European Perspectives on Hepatitis C. Volume 1: Burden of Disease. Pages; 6, 8 & 10.

COMM00367 April 2009

Contacts: Mike Nelson, Roche, +41-79-572-5165,; Shanchari Guha Roy, Ketchum, +44(0)207-611-3631,